Last Update 13 Aug 26
Fair value Decreased 2.59%4188: Revised Earnings Outlook And Lower P/E Will Support Fair Value
Analysts have trimmed their price target for Mitsubishi Chemical Group to about ¥1,158 from roughly ¥1,189, reflecting slightly lower revenue growth assumptions, a modestly higher profit margin outlook, and a revised future P/E expectation.
What’s in the News for Mitsubishi Chemical Group
- Mitsubishi Chemical Group raised its consolidated earnings guidance for the first half ending September 30, 2026, with expected sales revenue of ¥2,043.0b and operating income of ¥189.0b. Source: Company guidance.
- The company now expects first half net income of ¥130.0b and net income attributable to owners of the parent of ¥86.0b, with basic earnings per share of ¥63.30, compared with previous guidance of ¥43.43. Source: Company guidance.
- Management cited strong sales of semiconductor related products in the first quarter of the fiscal year ending March 31, 2027, along with higher naphtha prices and related inventory valuation effects and customer procurement, as key reasons for revising first half guidance. Source: Company guidance.
- The company also issued consolidated earnings guidance for the fiscal year ending March 31, 2027, projecting sales revenue of ¥3,800.0b and operating income of ¥300.0b. Source: Company guidance.
- For the same fiscal year, Mitsubishi Chemical Group guided to net income attributable to owners of the parent of ¥127.0b, or ¥93.48 in basic earnings per share. Source: Company guidance.
Valuation Changes
- Fair Value was revised lower from about ¥1,189.09 to roughly ¥1,158.33, indicating a small reduction in the estimated value for Mitsubishi Chemical Group.
- The Discount Rate was adjusted slightly from 6.96% to about 6.91%, suggesting only a minor change in the assumed risk level.
- Revenue Growth is now set at roughly 2.70% compared with the previous 3.20%, pointing to a more cautious growth outlook for sales.
- The Net Profit Margin was updated from around 3.98% to about 4.07%, reflecting a modestly higher expected level of profitability.
- The Future P/E moved from about 11.44x to roughly 10.69x, implying a slightly lower valuation multiple being used in the assumptions for Mitsubishi Chemical Group.
Key Takeaways
- Focus on specialty and sustainable materials, along with asset divestitures and efficiency measures, increases product value and stabilizes future earnings.
- Strong demand in technology and environmentally friendly segments, paired with strategic investments, supports revenue growth and improved profitability.
- Ongoing market oversupply, weak demand, tough competition, and delayed business shifts threaten profitability and margin recovery despite restructuring and cost-cutting efforts.
Catalysts
About Mitsubishi Chemical Group- Provides performance products, industrial materials, industrial gases, and others in Japan and internationally.
- Mitsubishi Chemical Group's ongoing shift towards specialty and high value-added materials-evidenced by significant structural reforms, business divestitures, and cost reductions-should enhance the product mix, improve net margins, and provide greater earnings stability as global demand for advanced, sustainable materials grows.
- Rising demand for display-related, semiconductor, and barrier packaging materials-directly tied to trends like electric vehicle proliferation and technology hardware growth-is already outpacing initial forecasts and is expected to contribute robustly to revenue and profit growth in upcoming periods.
- Investments in capacity expansion for bio-based and circular economy businesses (e.g., Soarnol for barrier packaging) position MCG to capitalize on increasing regulatory and customer preferences for sustainable products, which supports both top-line growth and future margin expansion.
- Ongoing operational efficiency initiatives-including automation, digitalization, and facility rationalization across segments such as carbon products and advanced composites-are beginning to deliver fixed cost reductions, suggesting further profitability improvements and SG&A savings ahead.
- Divestiture of non-core and underperforming assets (such as Mitsubishi Tanabe Pharma and real estate), combined with the redeployment of capital into specialty and advanced materials growth projects, is set to strengthen future earnings potential and improve balance sheet quality, supporting higher returns on invested capital.
Mitsubishi Chemical Group Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Mitsubishi Chemical Group's revenue will grow by 2.7% annually over the next 3 years.
- Analysts assume that profit margins will increase from -1.1% today to 4.1% in 3 years time.
- Analysts expect earnings to reach ¥168.6 billion (and earnings per share of ¥124.45) by about August 2029, up from -¥42.0 billion today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting ¥229.1 billion in earnings, and the most bearish expecting ¥142.2 billion.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 10.7x on those 2029 earnings, up from -40.4x today. This future PE is lower than the current PE for the JP Chemicals industry at 12.5x.
- Analysts expect the number of shares outstanding to decline by 2.12% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 6.91%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Persistent weakness and oversupply in the global MMA monomer and derivatives markets, especially from increased competition and volatile pricing in China and the broader Asian region, could continue to depress segment revenue and core operating income, directly pressuring long-term profitability.
- Delays and underachievement in shifting the Advanced Composites & Shapes and carbon fiber businesses from low-margin or loss-making applications (like wind turbine and pressure vessels) to higher-margin, high-value-added sectors (like aerospace and defense) could keep net margins suppressed and drag on consolidated earnings well into the future.
- Structural reforms and cost reduction efforts, while bringing some short-term savings, may not fully compensate for the severe headwinds in Basic Materials & Polymers, especially with ongoing challenges in upstream/downstream alignment and continued negative impacts from plant closures and rationalization, impacting long-term operating income growth.
- Exposure to foreign exchange volatility and persistently weak global demand-especially in regions impacted by U.S. tariffs, trade policy shifts, and slow recovery in industrial and automotive sectors-poses significant risk to sustaining or increasing revenue and net profit, particularly as global supply chain and policy uncertainty persist.
- Potential inability to achieve meaningful price increases or fully implement value-based pricing and cost-linked formulas in key product areas (notably in Asia ex-China and for core products like Soarnol and MMA) could hinder margin expansion and offset benefits from specialty material growth, limiting future revenue and earnings upside.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of ¥1158.33 for Mitsubishi Chemical Group based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ¥1700.0, and the most bearish reporting a price target of just ¥790.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be ¥4145.6 billion, earnings will come to ¥168.6 billion, and it would be trading on a PE ratio of 10.7x, assuming you use a discount rate of 6.9%.
- Given the current share price of ¥1246.5, the analyst price target of ¥1158.33 is 7.6% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Mitsubishi Chemical Group?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Comments
0 commentsDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.